Many are aware of the Cancer Moonshot—an ambitious and hopeful initiative of the U.S. government to reduce cancer-related death rates by 50% by the year 2047. To achieve this goal it will take a whole army, made up of the brightest minds in science, technology, and healthcare. Many parties will be involved—the federal government, healthcare providers, researchers, patients, caregivers, and advocates, among others in both the public and private sectors. Artificial intelligence (AI) is poised for revolutionizing cancer treatment and is one of the key tools that will help us achieve this lofty goal.
[time-brightcove not-tgx=”true”]
AI has the ability to improve all five of these areas. AI is particularly useful in two areas: the call for “deliver the latest cancer innovations to patients and communities” and the aim of enhancing “the oncology model to place cancer patients at the center of decision-making.”
In the history of cancer treatment, there has always been a constant process of improving treatments by using innovative methods and solutions. Take the example of prostate cancer. At first, the main treatment was surgery.
